| Scholarships and Salary Awards |
04/2006-03/2011
|
Canadian Institutes for Health Research (CIHR)
The role of iNOS in the pathogenesis of insulin resistance
$ 842,500.00 (100%) |
| 07/2001-06/2006 |
Canadian Institutes for Health Research
(CIHR)
The role of iNOS in the pathogenesis of insulin resistance
$ 350 000.00 (100%) (Investigator Award) |
| Research and Equipment Grants |
| 10/2005-09/2010 |
Canadian Institutes for Health Research (CIHR)
The role of mTOR in insulin resistance
$ 734 000.00 (100%) |
| 04/2001-03/2006 |
Canadian Institutes for Health Research (CIHR)
The role of iNOS in the pathogenesis of insulin resistance
$ 750 000.00 (100%) |
| 07/2005-06/2008 |
Canadian Diabetes Association
Role of AMPK and p38 MAPK pathways in exercise-induced glucose
transport in skeletal muscle: potential targets for the treatment
of muscle insulin resistance and diabetes
$ 225 000.00 (100%) |
| 10/2003-9/2006 |
Canadian Institutes for Health Research (CIHR)
Assesment of insulin sensitivity in insulin-resistant subjects
fed fish proteins
$ 265 000.00, (40%) (H. Jacques, A. Marette and J. Weisnagel) |
| 10/2003-9/2006 |
Canadian Institutes for Health Research (CIHR)
Intramyocellular lipids and insulin resistance in obesity and
diabetes
$ 348 000.00, (30%) (D. Joanisse (PI), A. Marette, A. Tremblay
and J. Weisnagel) |
| 10/2003-9/2008 |
Canadian Institutes for Health Research (CIHR)
Training Program in Obesity/Healthy Body Weight
$ 1 470 000.00, (15%)(D. Richard (PI), A. Marette (co-PI), 6
other co-PIs) |
| 07/2004-06/2009 |
Canadian Foundation for Innovation (CFI)
Montreal Diabetes Research Center : from biology to innovative
therapies
Program : Innovative Funds
$ 5 799 164.00, (10%) (M. Prentki, PI, A. Marette,co- PI, and
8 other co-PIs from UDM, McGill and UoOttawa). |
| 07/2005-06/2010 |
Canadian Foundation for Innovation (CFI)
Montreal Diabetes Research Centre: Linking Basic Science and
Clinical Research for Diabetes Prevention and Treatment
Program : Research Hospital Funds
$ 12 000 000.00, (10%) (M. Prentki PI, A. Marette, co- PI, and
8 other co-PIs, and 8 other co-PIs from UDM, McGill and UoOttawa). |
|
Industry Grants |
| 2005-2006 |
Innodia inc.
Mechanisms of action of ID 1101 and ID1135 on obesity and insulin
resistance in vivo and in vitro
$ 974 000.00 (100%) |
| 2005-2008 |
Merck Frosst
Fellowship Program grant on Incretins and β-cells
$90 000.00 (100%) |
|
